Dr. Mihaela Anastase, M.D.
What this data tells you about Dr. Anastase
Dr. Mihaela Anastase is a family medicine specialist in Wichita Falls, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Anastase performed 2,816 Medicare services across 1,737 unique beneficiaries.
Between the years covered by Open Payments, Dr. Anastase received a total of $8,455 from 36 pharmaceutical and/or device companies across 540 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Anastase is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 495 | $78 | $255 |
| Dexamethasone injection (steroid) | 370 | $0 | $2 |
| Blood draw (venipuncture) | 194 | $8 | $16 |
| Injection, ketorolac tromethamine, per 15 mg | 146 | $0 | $21 |
| Hospital follow-up visit, moderate complexity | 136 | $60 | $185 |
| Comprehensive metabolic blood panel | 135 | $10 | $79 |
| Drug injection, under skin or into muscle | 116 | $9 | $54 |
| Office visit, established patient (20-29 min) | 114 | $51 | $169 |
| Lipid panel (cholesterol and triglycerides) | 105 | $13 | $92 |
| Complete blood count (CBC) with differential | 104 | $8 | $27 |
| Thyroid stimulating hormone (TSH) test | 93 | $16 | $111 |
| Annual wellness visit, follow-up | 91 | $125 | $130 |
| Hemoglobin A1c test (diabetes monitoring) | 63 | $10 | $67 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 63 | $16 | $81 |
| Ceftriaxone antibiotic injection | 52 | $0 | $22 |
| Annual depression screening | 48 | $18 | $38 |
| Hospital follow-up visit, high complexity | 46 | $91 | $265 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 39 | $39 | $87 |
| Annual alcohol misuse screening, 5 to 15 minutes | 39 | $18 | $50 |
| Urinalysis with microscopic exam | 38 | $3 | $8 |
| Detection test by immunoassay with direct visual observation for influenza virus | 35 | $16 | $81 |
| Office visit, established patient (10-19 min) | 30 | $33 | $103 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 29 | $30 | $122 |
| Initial hospital admission, high complexity | 27 | $125 | $502 |
| Prostate cancer screening; prostate specific antigen test (psa) | 27 | $18 | $121 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 27 | $18 | $67 |
| Free thyroxine (T4) test | 25 | $9 | $60 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 20 | $40 | $162 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 20 | $25 | $75 |
| New patient office visit (30-44 min) | 19 | $80 | $257 |
| Urine microalbumin test (kidney screening) | 18 | $6 | $40 |
| Automated urinalysis | 17 | $2 | $16 |
| Vitamin D level test | 12 | $22 | $147 |
| Uric acid level test | 12 | $4 | $33 |
| Sed rate test (inflammation marker) | 11 | $3 | $18 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for family medicine in TX.
Geographic Context
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Anastase is a clinical cardiology specialist, with above-average Medicare volume (top 9% in TX), with low-engagement industry engagement in the top 7% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Anastase experienced with office visit, established patient (30-39 min)?
Does Dr. Anastase receive payments from pharmaceutical companies?
How do Dr. Anastase's costs compare to other family medicine physicians in Wichita Falls?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology